Pharma & Biopharma Manufacturing
WuXi Biologics Receives Bioprocessing Excellence Award from IMAPAC
This marks the second consecutive year that WuXi Bio has received this award from IMAPAC, a leading consulting firm in biopharmaceutical industry. S...
April 18, 2022 | News
GSK reaches agreement to acquire late-stage biopharmaceutical company Sierra Oncology for $1.9bn
Sierra Oncology’s differentiated momelotinib has the potential to address the critical unmet medical needs of myelofibrosis patients with anaemia ...
April 14, 2022 | News
Cambrex Completes Large-Scale US API Expansion
The startup of the new manufacturing space is the culmination of a two-year project, originally announced in 2020, to increase the capacity of Cambrex's fl...
April 13, 2022 | News
Daewoong Pharmaceutical and HanAll Biopharma Invest in Turn Biotechnologies to Expand Growth Initiative
Daewoong Pharmaceutical (KRX: 069620.KS) and HanAll Biopharma (KRX: 009420.KS) today announced expansion of their open collaboration strategy by inves...
April 12, 2022 | News
AGC to Expand Synthetic Pharmaceutical Production Base in Spain
A new building with a total floor area of 7,500 m2 will be constructed on the company's site, increasing the current production capacity by 30%. ...
April 11, 2022 | News
Nippon Express Acquire GDP Certification in Middle East
The United Arab Emirates (UAE) has been making focused efforts to attract the healthcare industry, and numerous pharmaceutical manufacturers and ...
March 30, 2022 | News
Expansion of Biologics CDMO & Manufacturing Capacity Offerings at Paras Biopharmaceuticals Finland
Due to the company’s technologies, its deep scientific knowhow and the specialized skills of the Paras Biopharma team, all of Paras Biopharmaceutical...
March 29, 2022 | News
Rentschler Biopharma and Vetter Unveil Xpert Alliance
Rentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organizations (CDMOs), announced today that t...
March 29, 2022 | News
BioVaxys Announces Bioproduction of BVX-1021
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company"), today announced that it has entered into an agreem...
March 21, 2022 | News
Veristat Expands its Expertise and Scale across Biopharma and Medtech
Veristat, a scientific-minded global clinical research organization (CRO), announced today the expansion and strengthening of its service capabilities by a...
March 08, 2022 | News
WuXi STA Passes the First EMA Drug Product Pre-Approval Inspection at its Wuxi City Site
The PAI focused on the drug product manufacturing of an innovative drug for one of WuXi STA’s partners. During a 5-day remote inspection from Novembe...
March 04, 2022 | News
Vetter’s extraordinary performance sweeps the board at the 2022 CMO Leadership Awards
Vetter’s high-level performance further substantiates its dedicated performance in customer-critical services Results affirm the approach, vision,...
March 03, 2022 | News
Thermo Fisher Scientific Continues Collaboration to Support Biopharmaceutical Discovery and Development
Thermo Fisher Scientific, the world leader in serving science, and Symphogen, an affiliate of and the antibody center of excellence within the internationa...
March 01, 2022 | News
GenScript Sets Up State-Of-Art Manufacturing Facility in Singapore to Strengthen Manufacturing Capability
The state-of-the-art site marks a significant expansion of the company's advanced protein and gene platforms, and is designed to provide high quality...
February 10, 2022 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
